NFKB1 and cancer: Furthermore, certain small molecules including proteasome inhibitor, NPI-0052, bortezomib, and nitric oxide (NO) donor DETA/NO are able to sensitize multiple cancer cell lines to chemotherapy-related apoptosis through NF-κB and Snail inhibition and RKIP induction [31, 74–76].